| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |